BioElectronics Corporation Share Price
Equities
BIEL
US09062H1086
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | -.--% | -.--% |
03-25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
02-23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
Sales 2020 | 830K 66.46M | Sales 2021 | 1.61M 129M | Capitalization | 25.6M 2.05B |
---|---|---|---|---|---|
Net income 2020 | -1M -80.11M | Net income 2021 | - 0 | EV / Sales 2020 | 53.6 x |
Net Debt 2020 | 13.07M 1.05B | Net Debt 2021 | 13.34M 1.07B | EV / Sales 2021 | 24.2 x |
P/E ratio 2020 |
-26.5
x | P/E ratio 2021 |
-95.5
x | Employees | 9 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
1 day | +100.00% | ||
Current month | -33.33% | ||
3 months | -33.33% | ||
6 months | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Kelly A. Whelan
CEO | Chief Executive Officer | - | 14/11/19 |
Keith E. Nalepka
SAM | Sales & Marketing | - | 31/08/17 |
John M. Martinez
PRN | Corporate Officer/Principal | - | 31/03/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 83 | 14/06/20 | |
Keith E. Nalepka
SAM | Sales & Marketing | - | 31/08/17 |
Kelly A. Whelan
CEO | Chief Executive Officer | - | 14/11/19 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 0.0002 | +100.00% | 2,485,000 |
29/04/24 | 0.0001 | -33.33% | 5,838,871 |
26/04/24 | 0.00015 | -25.00% | 28,245,000 |
25/04/24 | 0.0002 | -.--% | 7,306,938 |
24/04/24 | 0.0002 | +33.33% | 56,127,000 |
Delayed Quote OTC Markets, April 30, 2024 at 04:43 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-.--% | 2.47M | |
+7.15% | 220B | |
+6.60% | 183B | |
+9.86% | 133B | |
+24.32% | 107B | |
-0.95% | 63.05B | |
+11.04% | 51.74B | |
+4.81% | 50.47B | |
-1.43% | 40.91B | |
+24.40% | 31.91B |
- Stock Market
- Equities
- BIEL Stock